Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Citi
Federal Trade Commission
McKinsey
Farmers Insurance
Fuji
Medtronic
Covington
Argus Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

Olsalazine sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for olsalazine sodium and what is the scope of olsalazine sodium patent protection?

Olsalazine sodium
is the generic ingredient in one branded drug marketed by Mylan Speciality Lp and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for olsalazine sodium. Two suppliers are listed for this compound.
Pharmacology for olsalazine sodium
Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Synonyms for olsalazine sodium
15722-48-2 (Parent)
3,3 inverted exclamation mark -Azobis(6-hydroxybenzoic Acid) Sodium Salt
3,3'-(1,2-Diazenediyl)bis[6-hydroxybenzoic Acid Sodium Salt
3,3'-azo-bis(6-hydroxybenzoic acid) disodium salt
3.3'-azo-bis(6-hydroxybenzoic acid) disodium salt
4,4'-Dihydroxyazobenzene-3,3'-dicarboxylic Acid Disodium Salt
5,5'-Azobis(2-hydroxybenzoic Acid Sodium Salt)
6054-98-4
A832774
AB0106111
AC-666
AC1NSEDP
AC1O1BLU
ACT03232
AKOS015896356
AKOS015961136
AKOS025286102
AN-15656
Azodisal disodium
azodisal sodium
BC205785
Benzoic acid, 3,3'-(1,2-diazenediyl)bis(6-hydroxy-, sodium salt (1:2)
Benzoic acid, 3,3'-(1,2-diazenediyl)bis[6-hydroxy-, sodium salt (1:2)
Benzoic acid, 3,3'-azobis(6-hydroxy)
Benzoic acid, 3,3'-azobis[6-hydroxy-, disodium salt
C. I. Mordant Yellow 5, disodium salt
C.I. 14130
C14H8N2O6.2Na
CAS-6054-98-4
CCG-213070
CHEBI:63614
CHEMBL1201013
CHEMBL3187425
Chrome Yellow AS
CJ 91B
CJ-91B
CS-2050
CTK2F3102
D00727
di-5-ASA
Dipentum
Dipentum (TN)
disodium 3,3'-azobis (6-hydroxybenzoate)
disodium 3,3'-diazene-1,2-diylbis(6-hydroxybenzoate)
disodium 5-[(2E)-2-(3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-2-hydroxybenzoate
disodium 5-[(2Z)-2-(3-carboxylato-4-oxo-cyclohexa-2,5-dien-1-ylidene)hydrazino]-2-hydroxy-benzoate
disodium 5-[(2Z)-2-(3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-2-hydroxybenzoate
disodium 5-[2-(3-carboxylato-4-oxidanylidene-cyclohexa-2,5-dien-1-ylidene)hydrazinyl]-2-oxidanyl-benzoate
disodium 5-[2-(3-carboxylato-4-oxo-1-cyclohexa-2,5-dienylidene)hydrazinyl]-2-hydroxybenzoate
DISODIUM 5-{2-[(1Z)-3-CARBOXYLATO-4-OXOCYCLOHEXA-2,5-DIEN-1-YLIDENE]HYDRAZIN-1-YL}-2-HYDROXYBENZOATE
Disodium 5,5'-(Diazene-1,2-diyl)bis(2-hydroxybenzoate)
Disodium 5,5'-azodisalicylate
disodium;5-[(E)-(3-carboxylato-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoate
DSSTox_CID_26796
DSSTox_GSID_46796
DSSTox_RID_81912
DTXSID3046796
EINECS 227-975-7
FT-0657732
HMS3264H09
HMS3652I21
HY-B0174
I06-1888
KS-00000GV1
LS-36089
MFCD00013300
MolPort-003-849-701
MolPort-005-934-231
mordant yellow 5
NCGC00181008-01
O0517
Olsalazine (Disodium)
Olsalazine Disodium
Olsalazine disodium salt
Olsalazine sodium (USAN)
Olsalazine sodium [USAN]
Olsalazine Sodium Salt
OR069212
OR293623
PHCJ91B
s4041
SCHEMBL29767
Sodium azodisalicylate
sodium salt of a salicylate, disodium 3,3'-azobis (6-hydroxybenzoate)
ST51053274
Tox21_112658
UNII-Y7JEW0XG7I
Y7JEW0XG7I
ZJEFYLVGGFISGT-UHFFFAOYSA-L

US Patents and Regulatory Information for olsalazine sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp DIPENTUM olsalazine sodium CAPSULE;ORAL 019715-001 Jul 31, 1990 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Moodys
Medtronic
Cipla
Dow
Merck
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.